SangStat (nasdaq: SANG - news - people ) makes drugs used in transplantation.
FORBES: Magazine Article
The acquisition of SangStat gives Genzyme a new pipeline drug, RDP58, a protein that shuts down some of the molecular signals that cause inflammation.
FORBES: Genzyme To Buy SangStat For $600 Million
SangStat's transplant drug, Thymoglobin, may have the potential for further growth.
SangStat also sells a branded generic version of the transplant drug cyclosporine in partnership with Abbott Laboratories (nyse: ABT - news - people ).
应用推荐
模块上移
模块下移
不移动